Search Results 401-410 of 17234 for egfr

  1. Publications - Hee Eun Lee, M.D., Ph.D. - Mayo Clinic

    EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology. 2008 May; 52 (6):738-46 Epub 2008 ...

  2. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    Documented EGFR activating mutations (if already tested); Prior history of other malignancy except: Basal cell carcinoma of the skin; Cervical intra ...

  3. Open-label Trial of Daratumumab in Treatment of PGNIMD and C3 GN - Mayo Clinic

    eGFR ≥ 20 mL/min/SA; Subjects able and willing to give informed consent. Exclusion Criteria: Pregnancy; Hepatitis B or C, HIV; Multiple myeloma; Anemia with ...

  4. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

    ... (EGFR) mutations, with results available for collection in this study, and, if positive, has been treated with prior EGFR or ALK therapy. Received at least 1 ...

  5. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

    Cetuximab, panitumumab, or any other monoclonal antibody against EGFR or inhibitor of EGFR; BRAF inhibitor including, but not limited to, vemurafenib or ...

  6. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - Mayo Clinic

    * Confirmation that epidermal growth factor receptor- (EGFR-), anaplastic lymphoma kinase- (ALK-), or proto-oncogene tyrosine-protein kinase ROS (ROS1 ...

  7. A Dose Titration Study To Assess The Effects Of SAR407899 In Patients With Microvascular Angina And/or Persistent Stable Angina Despite Angiographically Successful Elective PCI - Mayo Clinic

    Renal impairment with estimated glomerular filtration rate (eGFR) <50 mL/min/1.73 m2 at screening and baseline. Drug-induced liver injury related criteria ...

  8. A Study to Assess Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) - Mayo Clinic

    ... eGFR > 29 mL/minute/1.73 m^2 in the highest tolerated dose expansion phase, and no current or likely need for hemodialysis in the next 12 months (a retest ...

  9. Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) - Mayo Clinic

    in order for a patient to be randomized. - Substantive renal disease (eGFR <30 mL/min/1.73m2calculated using the Cockcroft-Gault formula) - Echo derived ...

  10. Dual-Hormone Control of Post-absorptive and Post-prandial Glucose in Type 1 Diabetes - Mayo Clinic

    Creatinine ≤ 1.5 mg/dl or eGFR of >50 ml/min; no acute or chronic disease; current non-smoker; alcohol consumption <5 g/week; for women of child bearing ...